Microsoft India and Apollo Hospitals Group have established a National Clinical Coordination Committee (NCCC) in India for the Cardiovascular Disease Risk Score API with AI.
Founded in 1983, Apollo Hospitals was the first corporate hospital in India and is now one of the leading integrated health care groups in Asia with more than 71 hospitals and a network of pharmacies, primary care clinics, diagnostic centers, telemedicine centers, as well as medical education centers and a research base.
Cardiovascular diseases (CVD) are the leading cause of mortality in India with almost 25 percent of deaths, among the 25 to 69 age group. The condition also seems to affect Indians at least a decade earlier compared to Europeans.
Given the high prevalence, the first AI-driven CVD risk scoring API was launched in 2018, specifically designed to predict the risk of CVD in the Indian population. To date, more than 20,000 people have already been evaluated using the API and, in many cases, doctors have been able to predict the risk score of patients 5 to 7 years in advance.
As part of Microsoft's AI Network for Healthcare initiative and developed in Microsoft Azure, the API aims to determine a more accurate CVD risk score for the Indian population taking into account risk factors that include style attributes of life like diet, tobacco and smoking preferences, physical activity and stress and psychological anxiety.
Sangita Reddy, The Joint General Director of the Apollo Hospital Group believes that the NCCC will help immensely in the fight against the rising tsunami of Noncommunicable Diseases (NCDs). The NCCC will assist the central team of Apollo and Microsoft Hospitals by providing guidance on all AI projects related to cardiology and cardiovascular, as well as clinical ideas to develop clinical algorithms and treatment guidelines.
Apollo Hospitals and Microsoft India are already in discussion with health systems recognized worldwide to scale the API and contribute to the goal of the World Health Organization to reduce the risk of premature mortality from NCDs, including diseases cardiovascular, by 25% by 2025.